Trading News

Warren Buffett keeps selling billions worth of stock in this frothy market — here are 3 new places where he’s finding value

0

Motley Fool

1 Cancer Stock on Buyout Watch in 2022

The pharmaceutical industry appears poised for a record-breaking level of merger and acquisition (M&A) activity in 2022. First, Pfizer (NYSE: PFE) and Moderna are both flush with cash thanks to their novel coronavirus vaccines. Third, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Gilead Sciences, Johnson & Johnson, Merck, Moderna, Pfizer, and Sanofi are all expected to pursue bolt-on acquisitions next year to flesh out their clinical pipelines and product portfolios.

Four ways holiday shopping has changed since the pandemic began

Previous article

Here’s what history says about stock-market performance during the Thanksgiving week

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Trading News